+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Immunohistochemistry Market Size, Share & Trends Analysis Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Research), End-use (Hospitals & Diagnostic Laboratories), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 4621739
The Immunohistochemistry Market was valued at USD 2.40 billion in 2024, and is projected to reach USD 3.50 billion by 2030, rising at a CAGR of 6.93%. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.

The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.

Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.

Immunohistochemistry Market Report Highlights

  • The antibodies product segment led the market in 2024 owing to the high use of antibodies for immunohistochemistry assays carried out for disease diagnosis and drug testing workflows
  • The diagnostics application segment led the market in 2024 owing to the widespread application of IHC tests in diagnostic settings
  • The drug testing segment is expected to witness significant growth during the forecast period. This is due to increasing investment flow by pharmaceutical companies in R&D activities of novel drug discovery and development
  • The hospitals and diagnostic laboratories end-use segment accounted for the largest revenue share in 2024. Research institutes are expected to register the fastest CAGR over the forecast period owing to the increasing adoption of IHC in research institutes for drug discovery activities
  • North America emerged as the largest regional market in 2024 owing to the confluence of multiple factors, such as high cancer prevalence, presence of key players, and developed healthcare & biotechnological sectors
  • The Asia-Pacific is projected to grow at the fastest CAGR over the forecast period with China being the fastest-growing market. Increasing regulatory approvals and the launch of novel IHC solutions in China are accelerating the country’s market growth
  • Key players are engaged in making focused attempts to reinforce their market position and gain a competitive advantage

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Immunohistochemistry Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunohistochemistry Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Immunohistochemistry Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Immunohistochemistry Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Antibodies
4.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.3.2. Primary Antibodies
4.3.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.3.3. Secondary Antibodies
4.3.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Equipment
4.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Slide Staining System
4.4.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. Tissue Microarrays
4.4.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.4. Tissue Processing Systems
4.4.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.5. Slide Scanners
4.4.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.6. Others
4.4.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Reagents
4.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Histological stains
4.5.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Blocking Sera and Reagents
4.5.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.4. Chromogenic Substrates
4.5.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.5. Fixation Reagents
4.5.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.6. Stabilizers
4.5.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.7. Organic Solvents
4.5.7.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.8. Proteolytic Enzymes
4.5.8.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.9. Diluents
4.5.9.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Kits
4.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Immunohistochemistry Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Immunohistochemistry Market: Application Movement Analysis, 2024 & 2030 (USD Million)
5.3. Diagnostics
5.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.2. Cancer
5.3.2.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.3. Infectious Diseases
5.3.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.4. Cardiovascular Diseases
5.3.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.5. Autoimmune Diseases
5.3.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.6. Diabetes Mellitus
5.3.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.3.7. Nephrological Diseases
5.3.7.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Research
5.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Immunohistochemistry Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Immunohistochemistry Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
6.3. Hospitals & Diagnostic Laboratories
6.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Research Institutes
6.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Others
6.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Immunohistochemistry Market: Regional Estimates & Trend Analysis
7.1. Immunohistochemistry Market Share, By Region, 2024 & 2030 (USD Million)
7.2. North America
7.2.1. North America Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3. Europe
7.3.1. Europe Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.4. France
7.3.4.1. France Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.3. China
7.4.3.1. China Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.4. India
7.4.4.1. India Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. South Africa Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Immunohistochemistry Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. F. Hoffmann-La Roche Ltd.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Merck KGaA
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Danaher Corporation
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. PerkinElmer Inc.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Bio-Rad Laboratories, Inc.
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Cell Signaling Technology, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Bio SB
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Agilent Technologies, Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Abcam Limited.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global Immunohistochemistry market, by region, 2018-2030 (USD Million)
Table 3 Global Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 4 Global Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 5 Global Immunohistochemistry market, by End use, 2018-2030 (USD Million)
Table 6 North America Immunohistochemistry market, by country, 2018-2030 (USD Million)
Table 7 North America Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 8 North America Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 9 North America Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 10 U.S. Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 11 U.S. Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 12 U.S. Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 13 Canada Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 14 Canada Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 15 Canada Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 16 Mexico Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 17 Mexico Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 18 Mexico Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 19 Europe Immunohistochemistry market, by country, 2018-2030 (USD Million)
Table 20 Europe Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 21 Europe Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 22 Europe Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 23 UK Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 24 UK Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 25 UK Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 26 Germany Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 27 Germany Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 28 Germany Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 29 France Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 30 France Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 31 France Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 32 Italy Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 33 Italy Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 34 Italy Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 35 Spain Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 36 Spain Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 37 Spain Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 38 Denmark Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 39 Denmark Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 40 Denmark Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 41 Sweden Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 42 Sweden Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 43 Sweden Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 44 Norway Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 45 Norway Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 46 Norway Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 47 Asia Pacific Immunohistochemistry market, by country, 2018-2030 (USD Million)
Table 48 Asia Pacific Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 49 Asia Pacific Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 50 Asia Pacific Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 51 Japan Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 52 Japan Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 53 Japan Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 54 China Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 55 China Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 56 China Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 57 India Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 58 India Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 59 India Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 60 Australia Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 61 Australia Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 62 Australia Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 63 South Korea Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 64 South Korea Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 65 South Korea Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 66 Thailand Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 67 Thailand Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 68 Thailand Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 69 Latin America Immunohistochemistry market, by country, 2018-2030 (USD Million)
Table 70 Latin America Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 71 Latin America Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 72 Latin America Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 73 Brazil Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 74 Brazil Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 75 Brazil Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 76 Argentina Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 77 Argentina Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 78 Argentina Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 79 MEA Immunohistochemistry market, by country, 2018-2030 (USD Million)
Table 80 MEA Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 81 MEA Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 82 MEA Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 83 South Africa Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 84 South Africa Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 85 South Africa Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 86 Saudi Arabia Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 87 Saudi Arabia Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 88 Saudi Arabia Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 89 UAE Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 90 UAE Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 91 UAE Immunohistochemistry market, by end use, 2018-2030 (USD Million)
Table 92 Kuwait Immunohistochemistry market, by product, 2018-2030 (USD Million)
Table 93 Kuwait Immunohistochemistry market, by application, 2018-2030 (USD Million)
Table 94 Kuwait Immunohistochemistry market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Immunohistochemistry market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Segment snapshot-2
Figure 15 Competitive landscape snapshot
Figure 16 Market trends & outlook
Figure 17 Porter’s five force analysis
Figure 18 PESTEL analysis
Figure 19 Immunohistochemistry market: Product outlook key takeaways
Figure 20 Immunohistochemistry market: Product movement analysis
Figure 21 Antibodies market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Primary Antibodies market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Secondary Antibodies market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Equipment market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 Slide Staining System market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Tissue Microarrays market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Tissue Processing Systems market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Slide Scanners market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 Histological stains market estimates and forecasts, 2018-2030 (USD Million)
Figure 32 Blocking Sera and Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Chromogenic Substrates market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Fixation Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Stabilizers market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Organic Solvents market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Proteolytic Enzymes market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 Diluents market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Kits market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Immunohistochemistry market: Application outlook key takeaways
Figure 41 Immunohistochemistry market: Application movement analysis
Figure 42 Infectious disease diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 44 Cancer market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Infectious Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 46 Cardiovascular Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Autoimmune Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Diabetes Mellitus market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Nephrological Diseases market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Research market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Immunohistochemistry market: End-use outlook key takeaways
Figure 52 Immunohistochemistry market: End use movement analysis
Figure 53 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Research Institutes market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Regional marketplace outlook, 2024 & 2030 (USD million)
Figure 57 Regional marketplace: Key takeaways
Figure 58 North America Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 U.S. Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 Canada Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Key country dynamics
Figure 64 Mexico Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Europe Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 UK Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Key country dynamics
Figure 69 Germany Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 70 Key country dynamics
Figure 71 France Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 Key country dynamics
Figure 73 Spain Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 Italy Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 76 Key country dynamics
Figure 77 Denmark Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 78 Key country dynamics
Figure 79 Sweden Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 80 Key country dynamics
Figure 81 Norway Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Asia Pacific Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 83 Key country dynamics
Figure 84 Japan Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 85 Key country dynamics
Figure 86 China Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 87 Key country dynamics
Figure 88 India Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 89 Key country dynamics
Figure 90 Australia Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 91 Key country dynamics
Figure 92 South Korea Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 93 Key country dynamics
Figure 94 Thailand Immunohistochemistry market estimates and forecasts, 2018-2030 (USD Million)
Figure 95 Key country dynamics
Figure 96 Market participant categorization
Figure 97 Immunohistochemistry market position analysis, 2024
Figure 98 Strategic framework

Companies Mentioned

The major companies featured in this Immunohistochemistry market report include:
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Danaher Corporation
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Bio SB
  • Agilent Technologies, Inc.
  • Abcam Limited.

Table Information